Main Session
Sep
29
PQA 07 - Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care
3543 - PD-L1 Inhibitors Consolidation Following Concurrent Chemoradiotherapy Improves Progression-Free Survival without Increasing Pneumonitis vs. PD-1 Inhibitors In Unresectable Stage III NSCLC
Presenter(s)
Xiaoli Liu, MBBS - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong